115 related articles for article (PubMed ID: 38472261)
1. Possible role of lncRNAs in amelioration of Parkinson's disease symptoms by transplantation of dopaminergic cells.
Amini A; Esmaeili F; Golpich M
NPJ Parkinsons Dis; 2024 Mar; 10(1):56. PubMed ID: 38472261
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of sensorimotor behavioral recovery in hemiparkinsonian rats with intrastriatal, intranigral, and intrasubthalamic nucleus dopaminergic transplants.
Mukhida K; Baker KA; Sadi D; Mendez I
J Neurosci; 2001 May; 21(10):3521-30. PubMed ID: 11331381
[TBL] [Abstract][Full Text] [Related]
3. [Effect of electroacupuncture regulating NLRP3/Caspase-1 pathway on pyroptosis of dopaminergic neurons in rats with Parkinson's disease].
Liu YY; Guo YB; Zhai HY; Lei DB; Wang H; Zhao SC; Liu PJ
Zhen Ci Yan Jiu; 2022 Nov; 47(11):983-92. PubMed ID: 36453675
[TBL] [Abstract][Full Text] [Related]
4. Association of the Plasma Long Non-coding RNA
Quan Y; Wang J; Wang S; Zhao J
Front Neurol; 2020; 11():532891. PubMed ID: 33329296
[No Abstract] [Full Text] [Related]
5. Neural stem cells transplantation combined with ethyl stearate improve PD rats motor behavior by promoting NSCs migration and differentiation.
Huang J; Yi L; Yang X; Zheng Q; Zhong J; Ye S; Li X; Li H; Chen D; Li C
CNS Neurosci Ther; 2023 Jun; 29(6):1571-1584. PubMed ID: 36924304
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.
Yue X; Hariri DJ; Caballero B; Zhang S; Bartlett MJ; Kaut O; Mount DW; Wüllner U; Sherman SJ; Falk T
Neuroscience; 2014 Jan; 258():385-400. PubMed ID: 24291725
[TBL] [Abstract][Full Text] [Related]
7. [Estrogen protects the dopaminergic neurons in substantia nigra against damage induced by 6-hydroxydopamine].
Meng JL; Ma YY; Luo HY; Kong SZ; He YW; Dong BC; Wu SH; He M
Sheng Li Xue Bao; 2008 Jun; 60(3):369-74. PubMed ID: 18560728
[TBL] [Abstract][Full Text] [Related]
8. Reduced dopaminergic neuron degeneration and global transcriptional changes in Parkinson's disease mouse brains engrafted with human neural stems during the early disease stage.
Pereira MCL; Boese AC; Murad R; Yin J; Hamblin MH; Lee JP
Exp Neurol; 2022 Jun; 352():114042. PubMed ID: 35271839
[TBL] [Abstract][Full Text] [Related]
9. Heat shock protein 60 affects behavioral improvement in a rat model of Parkinson's disease grafted with human umbilical cord mesenchymal stem cell-derived dopaminergic-like neurons.
Zhao C; Li H; Zhao XJ; Liu ZX; Zhou P; Liu Y; Feng MJ
Neurochem Res; 2016 Jun; 41(6):1238-49. PubMed ID: 26758268
[TBL] [Abstract][Full Text] [Related]
10. Ginsenoside Rb1 protects dopaminergic neurons from inflammatory injury induced by intranigral lipopolysaccharide injection.
Li DW; Zhou FZ; Sun XC; Li SC; Yang JB; Sun HH; Wang AH
Neural Regen Res; 2019 Oct; 14(10):1814-1822. PubMed ID: 31169200
[TBL] [Abstract][Full Text] [Related]
11. STAT3 protects dopaminergic neurons against degeneration in animal model of Parkinson's disease.
Smit RD; Ghosh B; Campion TJ; Stingel R; Lavell E; Hooper R; Fan X; Soboloff J; Smith GM
Brain Res; 2024 Feb; 1824():148691. PubMed ID: 38030102
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of garlic extract on dopaminergic neurons of substantia nigra in a rat model of Parkinson's disease: motor and non-motor outcomes.
Bigham M; Mohammadipour A; Hosseini M; Malvandi AM; Ebrahimzadeh-Bideskan A
Metab Brain Dis; 2021 Jun; 36(5):927-937. PubMed ID: 33656625
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potentials of human microfluidic encapsulated conjunctival mesenchymal stem cells on the rat model of Parkinson's disease.
Forouzandeh M; Bigdeli MR; Mostafavi H; Nadri S; Eskandari M
Exp Mol Pathol; 2021 Dec; 123():104703. PubMed ID: 34619140
[TBL] [Abstract][Full Text] [Related]
14. [Protective effect of alkaloids from Piper longum in rat dopaminergic neuron injury of 6-OHDA-induced Parkinson's disease].
Zheng L; Wang H; Ba YY; Liu HL; Wang M; Guo WW; Wu X; Yang H
Zhongguo Zhong Yao Za Zhi; 2014 May; 39(9):1660-5. PubMed ID: 25095380
[TBL] [Abstract][Full Text] [Related]
15. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
[TBL] [Abstract][Full Text] [Related]
16. Cotransplantation of NSCs and ethyl stearate promotes synaptic plasticity in PD rats by Drd1/ERK/AP-1 signaling pathway.
Yi L; Ma H; Yang X; Zheng Q; Zhong J; Ye S; Li X; Chen D; Li H; Li C
J Ethnopharmacol; 2024 Mar; 321():117292. PubMed ID: 37806537
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
Oiwa Y; Yoshimura R; Nakai K; Itakura T
Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
[TBL] [Abstract][Full Text] [Related]
18. The effect of dopaminergic neuron transplantation and melatonin co-administration on oxidative stress-induced cell death in Parkinson's disease.
Asemi-Rad A; Moafi M; Aliaghaei A; Abbaszadeh HA; Abdollahifar MA; Ebrahimi MJ; Heidari MH; Sadeghi Y
Metab Brain Dis; 2022 Dec; 37(8):2677-2685. PubMed ID: 36074314
[TBL] [Abstract][Full Text] [Related]
19. Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinson's Disease.
Teixeira FG; Vilaça-Faria H; Domingues AV; Campos J; Salgado AJ
Cells; 2020 Jan; 9(2):. PubMed ID: 32012897
[TBL] [Abstract][Full Text] [Related]
20. Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats.
Pang Y; Lin S; Wright C; Shen J; Carter K; Bhatt A; Fan LW
Neuroscience; 2016 Mar; 318():157-65. PubMed ID: 26777890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]